Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s share price traded down 1.2% during mid-day trading on Thursday . The stock traded as low as $5.55 and last traded at $5.55. 12,849 shares traded hands during mid-day trading, a decline of 29% from the average session volume of 18,080 shares. The stock had previously closed at $5.62.
Ono Pharmaceutical Stock Performance
The company’s 50 day moving average is $4.99 and its 200 day moving average is $4.38.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.
Featured Articles
- Five stocks we like better than Ono Pharmaceutical
- 3 Signs You May Want to Switch Financial Advisors
- Your name isn’t on our protected list yet
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- Silver paying 20% dividend. Plus 68% share gains
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
